341170 fundamentals
Key facts
Future Medicine Co., Ltd. is a synthetic new drug development company, which engages in the development of specialized drugs with high medical unmet needs based on the FOCUS TM platform based on nucleoside derivatives. Its products include Anti-inflammatory/anti-fibrotic agent (FM101), Targeted anticancer drugs (FM301), Immunotherapy (FM401), Metabolic anticancer agent (FM701), Autoimmune disease/Targeted anticancer drugs (FM501), Antiviral (FM203), and Anti-obesity drug (FM801). The company was founded on June 4, 2015 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company